<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2003-11-28" modified="2017-11-22" version="170">
<accession>O43293</accession>
<accession>A0AVN4</accession>
<accession>B3KQE2</accession>
<accession>Q05JY4</accession>
<name>DAPK3_HUMAN</name>
<protein>
<recommendedName>
<fullName>Death-associated protein kinase 3</fullName>
<shortName>DAP kinase 3</shortName>
<ecNumber evidence="9 10 11 13 19 25">2.7.11.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>DAP-like kinase</fullName>
<shortName>Dlk</shortName>
</alternativeName>
<alternativeName>
<fullName>MYPT1 kinase</fullName>
</alternativeName>
<alternativeName>
<fullName>Zipper-interacting protein kinase</fullName>
<shortName>ZIP-kinase</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">DAPK3</name>
<name type="synonym">ZIPK</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1" evidence="35">
<citation type="journal article" date="1998" name="Mol. Cell. Biol." volume="18" first="1642" last="1651">
<title>ZIP kinase, a novel serine/threonine kinase which mediates apoptosis.</title>
<authorList>
<person name="Kawai T."/>
<person name="Matsumoto M."/>
<person name="Takeda K."/>
<person name="Sanjo H."/>
<person name="Akira S."/>
</authorList>
<dbReference type="PubMed" id="9488481"/>
<dbReference type="DOI" id="10.1128/MCB.18.3.1642"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2" evidence="35">
<citation type="journal article" date="1999" name="FEBS Lett." volume="451" first="81" last="84">
<title>ZIP kinase identified as a novel myosin regulatory light chain kinase in HeLa cells.</title>
<authorList>
<person name="Murata-Hori M."/>
<person name="Suizu F."/>
<person name="Iwasaki T."/>
<person name="Kikuchi A."/>
<person name="Hosoya H."/>
</authorList>
<dbReference type="PubMed" id="10356987"/>
<dbReference type="DOI" id="10.1016/S0014-5793(99)00550-5"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>COFACTOR</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2006" name="Arch. Biochem. Biophys." volume="456" first="194" last="203">
<title>Novel ZIP kinase isoform lacks leucine zipper.</title>
<authorList>
<person name="Takamoto N."/>
<person name="Komatsu S."/>
<person name="Komaba S."/>
<person name="Niiro N."/>
<person name="Ikebe M."/>
</authorList>
<dbReference type="PubMed" id="17126281"/>
<dbReference type="DOI" id="10.1016/j.abb.2006.09.026"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 165-454 (ISOFORM 2)</scope>
<scope>ALTERNATIVE SPLICING</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF MYOSIN; PPP1R12A AND MYL12B</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>INTERACTION WITH PPP1R12A AND MYOSIN</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Urinary bladder</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="29567" last="29574">
<title>Zipper-interacting protein kinase induces Ca(2+)-free smooth muscle contraction via myosin light chain phosphorylation.</title>
<authorList>
<person name="Niiro N."/>
<person name="Ikebe M."/>
</authorList>
<dbReference type="PubMed" id="11384979"/>
<dbReference type="DOI" id="10.1074/jbc.M102753200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF MUSCLE MYL12B</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2001" name="Oncogene" volume="20" first="8175" last="8183">
<title>HeLa ZIP kinase induces diphosphorylation of myosin II regulatory light chain and reorganization of actin filaments in nonmuscle cells.</title>
<authorList>
<person name="Murata-Hori M."/>
<person name="Fukuta Y."/>
<person name="Ueda K."/>
<person name="Iwasaki T."/>
<person name="Hosoya H."/>
</authorList>
<dbReference type="PubMed" id="11781833"/>
<dbReference type="DOI" id="10.1038/sj.onc.1205055"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF NON-MUSCLE MYL12B</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="8" evidence="35">
<citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="6174" last="6186">
<title>ZIP kinase triggers apoptosis from nuclear PML oncogenic domains.</title>
<authorList>
<person name="Kawai T."/>
<person name="Akira S."/>
<person name="Reed J.C."/>
</authorList>
<dbReference type="PubMed" id="12917339"/>
<dbReference type="DOI" id="10.1128/MCB.23.17.6174-6186.2003"/>
</citation>
<scope>FUNCTION IN APOPTOSIS</scope>
<scope>INTERACTION WITH DAXX AND PAWR</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="42055" last="42061">
<title>Identification and characterization of zipper-interacting protein kinase as the unique vascular smooth muscle myosin phosphatase-associated kinase.</title>
<authorList>
<person name="Endo A."/>
<person name="Surks H.K."/>
<person name="Mochizuki S."/>
<person name="Mochizuki N."/>
<person name="Mendelsohn M.E."/>
</authorList>
<dbReference type="PubMed" id="15292222"/>
<dbReference type="DOI" id="10.1074/jbc.M403676200"/>
</citation>
<scope>INTERACTION WITH PPP1R12A</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="J. Cell Biol." volume="165" first="243" last="254">
<title>ZIP kinase is responsible for the phosphorylation of myosin II and necessary for cell motility in mammalian fibroblasts.</title>
<authorList>
<person name="Komatsu S."/>
<person name="Ikebe M."/>
</authorList>
<dbReference type="PubMed" id="15096528"/>
<dbReference type="DOI" id="10.1083/jcb.200309056"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF MYL12B</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="8611" last="8626">
<title>Death-associated protein kinase phosphorylates ZIP kinase, forming a unique kinase hierarchy to activate its cell death functions.</title>
<authorList>
<person name="Shani G."/>
<person name="Marash L."/>
<person name="Gozuacik D."/>
<person name="Bialik S."/>
<person name="Teitelbaum L."/>
<person name="Shohat G."/>
<person name="Kimchi A."/>
</authorList>
<dbReference type="PubMed" id="15367680"/>
<dbReference type="DOI" id="10.1128/MCB.24.19.8611-8626.2004"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT THR-299; SER-309; SER-311; SER-312; SER-318 AND SER-326</scope>
<scope>PHOSPHORYLATION BY DAPK1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2005" name="Int. Immunol." volume="17" first="1543" last="1552">
<title>Physical and functional interactions between STAT3 and ZIP kinase.</title>
<authorList>
<person name="Sato N."/>
<person name="Kawai T."/>
<person name="Sugiyama K."/>
<person name="Muromoto R."/>
<person name="Imoto S."/>
<person name="Sekine Y."/>
<person name="Ishida M."/>
<person name="Akira S."/>
<person name="Matsuda T."/>
</authorList>
<dbReference type="PubMed" id="16219639"/>
<dbReference type="DOI" id="10.1093/intimm/dxh331"/>
</citation>
<scope>INTERACTION WITH STAT3</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2005" name="Int. J. Androl." volume="28" first="163" last="170">
<title>TCP10L is expressed specifically in spermatogenic cells and binds to death associated protein kinase-3.</title>
<authorList>
<person name="Yu H."/>
<person name="Jiang D."/>
<person name="Guo Z."/>
<person name="Saiyin H."/>
<person name="Guo J."/>
<person name="Wang X."/>
<person name="Yu L."/>
</authorList>
<dbReference type="PubMed" id="15910542"/>
<dbReference type="DOI" id="10.1111/j.1365-2605.2005.00522.x"/>
</citation>
<scope>INTERACTION WITH TCP10L</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="9363" last="9374">
<title>Regulation of zipper-interacting protein kinase activity in vitro and in vivo by multisite phosphorylation.</title>
<authorList>
<person name="Graves P.R."/>
<person name="Winkfield K.M."/>
<person name="Haystead T.A."/>
</authorList>
<dbReference type="PubMed" id="15611134"/>
<dbReference type="DOI" id="10.1074/jbc.M412538200"/>
</citation>
<scope>PHOSPHORYLATION AT THR-180; THR-225; THR-265; THR-299; THR-306 AND SER-311</scope>
<scope>ENZYME REGULATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF THR-299; 299-THR-THR-300; VAL-427; VAL-434 AND LEU-441</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="Annu. Rev. Biochem." volume="75" first="189" last="210">
<title>The death-associated protein kinases: structure, function, and beyond.</title>
<authorList>
<person name="Bialik S."/>
<person name="Kimchi A."/>
</authorList>
<dbReference type="PubMed" id="16756490"/>
<dbReference type="DOI" id="10.1146/annurev.biochem.75.103004.142615"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="4884" last="4893">
<title>ROCK1 phosphorylates and activates zipper-interacting protein kinase.</title>
<authorList>
<person name="Hagerty L."/>
<person name="Weitzel D.H."/>
<person name="Chambers J."/>
<person name="Fortner C.N."/>
<person name="Brush M.H."/>
<person name="Loiselle D."/>
<person name="Hosoya H."/>
<person name="Haystead T.A."/>
</authorList>
<dbReference type="PubMed" id="17158456"/>
<dbReference type="DOI" id="10.1074/jbc.M609990200"/>
</citation>
<scope>FUNCTION</scope>
<scope>ENZYME REGULATION</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>PHOSPHORYLATION AT THR-180; THR-265 AND THR-299</scope>
<scope>MUTAGENESIS OF LYS-42; ASP-161; THR-225; THR-265 AND THR-299</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2007" name="PLoS Genet." volume="3" first="1884" last="1893">
<title>ZIPK: a unique case of murine-specific divergence of a conserved vertebrate gene.</title>
<authorList>
<person name="Shoval Y."/>
<person name="Pietrokovski S."/>
<person name="Kimchi A."/>
</authorList>
<dbReference type="PubMed" id="17953487"/>
<dbReference type="DOI" id="10.1371/journal.pgen.0030180"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>ABSENCE OF INTERACTION WITH PARW</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2007" name="Signal Transduct." volume="7" first="248" last="259">
<title>Dlk/ZIP kinase, a novel Ser/Thr-specific protein kinase with multiple functions.</title>
<authorList>
<person name="Scheidtmann K.H."/>
</authorList>
<dbReference type="DOI" id="10.1002/sita.200600112"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2008" name="Mol. Cell" volume="32" first="371" last="382">
<title>DAPK-ZIPK-L13a axis constitutes a negative-feedback module regulating inflammatory gene expression.</title>
<authorList>
<person name="Mukhopadhyay R."/>
<person name="Ray P.S."/>
<person name="Arif A."/>
<person name="Brady A.K."/>
<person name="Kinter M."/>
<person name="Fox P.L."/>
</authorList>
<dbReference type="PubMed" id="18995835"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.09.019"/>
</citation>
<scope>FUNCTION IN PHOSPHPRYLATION OF RPL13A</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2008" name="Oncogene" volume="27" first="3292" last="3300">
<title>ZIP kinase plays a crucial role in androgen receptor-mediated transcription.</title>
<authorList>
<person name="Leister P."/>
<person name="Felten A."/>
<person name="Chasan A.I."/>
<person name="Scheidtmann K.H."/>
</authorList>
<dbReference type="PubMed" id="18084323"/>
<dbReference type="DOI" id="10.1038/sj.onc.1210995"/>
</citation>
<scope>FUNCTION IN ANDROGEN RECEPTOR-MEDIATED TRANSCRIPTION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2011" name="Cancer Res." volume="71" first="3152" last="3161">
<title>Cancer-associated loss-of-function mutations implicate DAPK3 as a tumor-suppressing kinase.</title>
<authorList>
<person name="Brognard J."/>
<person name="Zhang Y.W."/>
<person name="Puto L.A."/>
<person name="Hunter T."/>
</authorList>
<dbReference type="PubMed" id="21487036"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-10-3543"/>
</citation>
<scope>FUNCTION AS TUMOR SUPPRESSOR</scope>
<scope>CHARACTERIZATION OF VARIANTS MET-112; ASN-161 AND SER-216</scope>
<scope>MUTAGENESIS OF THR-180</scope>
<scope>SELF-ASSOCIATION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2011" name="Cell. Signal." volume="23" first="297" last="303">
<title>Phosphorylation-dependent control of ZIPK nuclear import is species specific.</title>
<authorList>
<person name="Weitzel D.H."/>
<person name="Chambers J."/>
<person name="Haystead T.A."/>
</authorList>
<dbReference type="PubMed" id="20854903"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2010.09.016"/>
</citation>
<scope>PHOSPHORYLATION AT THR-299</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF 294-ARG-ARG-295</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2011" name="EMBO J." volume="30" first="636" last="651">
<title>Atg1-mediated myosin II activation regulates autophagosome formation during starvation-induced autophagy.</title>
<authorList>
<person name="Tang H.W."/>
<person name="Wang Y.B."/>
<person name="Wang S.L."/>
<person name="Wu M.H."/>
<person name="Lin S.Y."/>
<person name="Chen G.C."/>
</authorList>
<dbReference type="PubMed" id="21169990"/>
<dbReference type="DOI" id="10.1038/emboj.2010.338"/>
</citation>
<scope>FUNCTION IN REGULATION OF AUTOPHAGY</scope>
<scope>INTERACTION WITH ULK1</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="19170" last="19177">
<title>Zipper-interacting protein kinase (ZIPK) modulates canonical Wnt/beta-catenin signaling through interaction with Nemo-like kinase and T-cell factor 4 (NLK/TCF4).</title>
<authorList>
<person name="Togi S."/>
<person name="Ikeda O."/>
<person name="Kamitani S."/>
<person name="Nakasuji M."/>
<person name="Sekine Y."/>
<person name="Muromoto R."/>
<person name="Nanbo A."/>
<person name="Oritani K."/>
<person name="Kawai T."/>
<person name="Akira S."/>
<person name="Matsuda T."/>
</authorList>
<dbReference type="PubMed" id="21454679"/>
<dbReference type="DOI" id="10.1074/jbc.M110.189829"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NLK</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2011" name="PLoS ONE" volume="6" first="E17344" last="E17344">
<title>New modularity of DAP-kinases: alternative splicing of the DRP-1 gene produces a ZIPk-like isoform.</title>
<authorList>
<person name="Shoval Y."/>
<person name="Berissi H."/>
<person name="Kimchi A."/>
<person name="Pietrokovski S."/>
</authorList>
<dbReference type="PubMed" id="21408167"/>
<dbReference type="DOI" id="10.1371/journal.pone.0017344"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ATF4</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2013" name="Biochem. Biophys. Res. Commun." volume="433" first="163" last="169">
<title>Interaction of RhoD and ZIP kinase modulates actin filament assembly and focal adhesion dynamics.</title>
<authorList>
<person name="Nehru V."/>
<person name="Almeida F.N."/>
<person name="Aspenstrom P."/>
</authorList>
<dbReference type="PubMed" id="23454120"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2013.02.046"/>
</citation>
<scope>FUNCTION IN REORGANIZATION OF ACTIN CYTOSKELETON</scope>
<scope>INTERACTION WITH RHOD</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-312</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="28">
<citation type="submission" date="2006-06" db="PDB data bank">
<title>Crystal structure of human ZIP kinase.</title>
<authorList>
<person name="Kursula P."/>
<person name="Vahokoski J."/>
<person name="Wilmanns M."/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) OF 1-277</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2008" name="EMBO J." volume="27" first="704" last="714">
<title>Activation segment dimerization: a mechanism for kinase autophosphorylation of non-consensus sites.</title>
<authorList>
<person name="Pike A.C."/>
<person name="Rellos P."/>
<person name="Niesen F.H."/>
<person name="Turnbull A."/>
<person name="Oliver A.W."/>
<person name="Parker S.A."/>
<person name="Turk B.E."/>
<person name="Pearl L.H."/>
<person name="Knapp S."/>
</authorList>
<dbReference type="PubMed" id="18239682"/>
<dbReference type="DOI" id="10.1038/emboj.2008.8"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 9-289 IN COMPLEX WITH PYRIDONE 6</scope>
<scope>ENZYME REGULATION</scope>
<scope>SUBUNIT</scope>
<scope>PHOSPHORYLATION AT SER-50 AND THR-265</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] MET-112; ASN-161 AND SER-216</scope>
</reference>
<comment type="function">
<text evidence="9 10 11 12 13 15 18 19 20 23 25 27 28 29 30 31">Serine/threonine kinase which is involved in the regulation of apoptosis, autophagy, transcription, translation and actin cytoskeleton reorganization. Involved in the regulation of smooth muscle contraction. Regulates both type I (caspase-dependent) apoptotic and type II (caspase-independent) autophagic cell deaths signal, depending on the cellular setting. Involved in regulation of starvation-induced autophagy. Regulates myosin phosphorylation in both smooth muscle and non-muscle cells. In smooth muscle, regulates myosin either directly by phosphorylating MYL12B and MYL9 or through inhibition of smooth muscle myosin phosphatase (SMPP1M) via phosphorylation of PPP1R12A; the inhibition of SMPP1M functions to enhance muscle responsiveness to Ca(2+) and promote a contractile state. Phosphorylates MYL12B in non-muscle cells leading to reorganization of actin cytoskeleton. Isoform 2 can phosphorylate myosin, PPP1R12A and MYL12B. Overexpression leads to condensation of actin stress fibers into thick bundles. Involved in actin filament focal adhesion dynamics. The function in both reorganization of actin cytoskeleton and focal adhesion dissolution is modulated by RhoD. Positively regulates canonical Wnt/beta-catenin signaling through interaction with NLK and TCF7L2. Phosphorylates RPL13A on 'Ser-77' upon interferon-gamma activation which is causing RPL13A release from the ribosome, RPL13A association with the GAIT complex and its subsequent involvement in transcript-selective translation inhibition. Enhances transcription from AR-responsive promoters in a hormone- and kinase-dependent manner. Involved in regulation of cell cycle progression and cell proliferation. May be a tumor suppressor.</text>
</comment>
<comment type="catalytic activity">
<text evidence="9 10 11 13 19 25">ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="cofactor">
<cofactor evidence="9">
<name>Mg(2+)</name>
<dbReference type="ChEBI" id="CHEBI:18420"/>
</cofactor>
</comment>
<comment type="enzyme regulation">
<text evidence="16 20 24 33">A sequential activation is proposed: autophosphorylation at consensus sites is leading to dimerization of the catalytic domain stabilized by phosphorylation at Ser-50 and activation segment exchange (producing an active confirmation of both kinase modules in trans) followed by phosphorylation at Thr-180 in the activation segment and at other regulatory sites (Probable). Phosphorylation at Thr-180, Thr-225 and Thr-265 is essential for activity. Oligomerization is required for full enzymatic activity. Inhibited by pyridone 6 (K00225), a potent, ATP-competitive inhibitor.</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="19">12 uM for myosin (isoform 2)</KM>
<KM evidence="19">6.2 uM for myosin (isoform 1)</KM>
<KM evidence="19">73 uM for MYL12B (isoform 2)</KM>
<KM evidence="19">10.4 uM for MYL12B (isoform 1)</KM>
<Vmax evidence="19">248 nmol/min/mg enzyme toward myosin (isoform 2)</Vmax>
<Vmax evidence="19">120 nmol/min/mg enzyme toward myosin (isoform 1)</Vmax>
<Vmax evidence="19">1.3 umol/min/mg enzyme toward MYL12B (isoform 2)</Vmax>
<Vmax evidence="19">271 nmol/min/mg enzyme toward MYL12B (isoform 1)</Vmax>
</kinetics>
</comment>
<comment type="subunit">
<text evidence="12 14 17 18 19 24 27 28 29 31 33">Homooligomer in its kinase-active form (homotrimers and homodimers are reported); monomeric in its kinase-inactive form. Homodimerization is required for activation segment autophosphorylation (Probable). Isoform 1 and isoform 2 interact with myosin and PPP1R12A; interaction of isoform 1 with PPP1R12A is inhibited by RhoA dominant negative form. Interacts with NLK, DAXX, STAT3, RHOD (GTP-bound form) and TCP10L. Interacts with PAWR; the interaction is reported conflictingly: according to PubMed:17953487 does not interact with PAWR. Interacts with ULK1; may be a substrate of ULK1.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-77293"/>
<interactant intactId="EBI-77293"/>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-77293"/>
<interactant intactId="EBI-366978">
<id>Q9UBE8</id>
<label>NLK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-77293"/>
<interactant intactId="EBI-351726">
<id>O14974</id>
<label>PPP1R12A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9691390"/>
<interactant intactId="EBI-918263">
<id>Q10728</id>
<label>Ppp1r12a</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-77293"/>
<interactant intactId="EBI-3923210">
<id>Q8TDR4</id>
<label>TCP10L</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="15 17 26">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="15 16 22 26">Cytoplasm</location>
</subcellularLocation>
<text evidence="22 26">Predominantly localizes to the cytoplasm but can shuttle between the nucleus and cytoplasm; cytoplasmic localization is promoted by phosphorylation at Thr-299 and involves Rho/Rock signaling.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 1</molecule>
<subcellularLocation>
<location evidence="19">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="19">Cytoplasm</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 2</molecule>
<subcellularLocation>
<location evidence="19">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="19">Cytoplasm</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>O43293-1</id>
<name>1</name>
<name>ZIPK-L</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>O43293-2</id>
<name>2</name>
<name>ZIPK-S</name>
<sequence type="described" ref="VSP_042059 VSP_042060"/>
<text>The internal splice site between exon 8 and the 3' UTR, which yields this truncated isoform, is non-canonical.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="14 19">Widely expressed. Isoform 1 and isoform 2 are expressed in the bladder smooth muscle.</text>
</comment>
<comment type="PTM">
<text evidence="15 16 20 26">The phosphorylation status is critical for kinase activity, oligomerization and intracellular localization. Phosphorylation at Thr-180, Thr-225 and Thr-265 is essential for activity. The phosphorylated form is localized in the cytoplasm promoted by phosphorylation at Thr-299; nuclear translocation or retention is maximal when it is not phosphorylated. Phosphorylation increases the trimeric form, and its dephosphorylation favors a kinase-inactive monomeric form. Both isoform 1 and isoform 2 can undergo autophosphorylation.</text>
</comment>
<comment type="similarity">
<text evidence="35">Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family. DAP kinase subfamily.</text>
</comment>
<dbReference type="EC" id="2.7.11.1" evidence="9 10 11 13 19 25"/>
<dbReference type="EMBL" id="AB007144">
<property type="protein sequence ID" value="BAA24955.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB022341">
<property type="protein sequence ID" value="BAA81746.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK074799">
<property type="protein sequence ID" value="BAG52004.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC126430">
<property type="protein sequence ID" value="AAI26431.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC126432">
<property type="protein sequence ID" value="AAI26433.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB265224">
<property type="protein sequence ID" value="BAF34614.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS12116.1">
<molecule id="O43293-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001339.1">
<molecule id="O43293-1"/>
<property type="nucleotide sequence ID" value="NM_001348.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005259565.1">
<molecule id="O43293-1"/>
<property type="nucleotide sequence ID" value="XM_005259508.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.631844"/>
<dbReference type="PDB" id="1YRP">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A/B=1-277"/>
</dbReference>
<dbReference type="PDB" id="2J90">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=9-289"/>
</dbReference>
<dbReference type="PDB" id="3BHY">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.24"/>
<property type="chains" value="A=9-289"/>
</dbReference>
<dbReference type="PDB" id="3BQR">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A=9-289"/>
</dbReference>
<dbReference type="PDB" id="5A6N">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A/B=9-289"/>
</dbReference>
<dbReference type="PDB" id="5A6O">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A/B=9-289"/>
</dbReference>
<dbReference type="PDBsum" id="1YRP"/>
<dbReference type="PDBsum" id="2J90"/>
<dbReference type="PDBsum" id="3BHY"/>
<dbReference type="PDBsum" id="3BQR"/>
<dbReference type="PDBsum" id="5A6N"/>
<dbReference type="PDBsum" id="5A6O"/>
<dbReference type="ProteinModelPortal" id="O43293"/>
<dbReference type="SMR" id="O43293"/>
<dbReference type="BioGrid" id="107983">
<property type="interactions" value="56"/>
</dbReference>
<dbReference type="IntAct" id="O43293">
<property type="interactions" value="46"/>
</dbReference>
<dbReference type="MINT" id="MINT-6505325"/>
<dbReference type="STRING" id="9606.ENSP00000301264"/>
<dbReference type="BindingDB" id="O43293"/>
<dbReference type="ChEMBL" id="CHEMBL2468"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2004"/>
<dbReference type="iPTMnet" id="O43293"/>
<dbReference type="PhosphoSitePlus" id="O43293"/>
<dbReference type="BioMuta" id="DAPK3"/>
<dbReference type="EPD" id="O43293"/>
<dbReference type="MaxQB" id="O43293"/>
<dbReference type="PaxDb" id="O43293"/>
<dbReference type="PeptideAtlas" id="O43293"/>
<dbReference type="PRIDE" id="O43293"/>
<dbReference type="DNASU" id="1613"/>
<dbReference type="Ensembl" id="ENST00000301264">
<molecule id="O43293-1"/>
<property type="protein sequence ID" value="ENSP00000301264"/>
<property type="gene ID" value="ENSG00000167657"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000545797">
<molecule id="O43293-1"/>
<property type="protein sequence ID" value="ENSP00000442973"/>
<property type="gene ID" value="ENSG00000167657"/>
</dbReference>
<dbReference type="GeneID" id="1613"/>
<dbReference type="KEGG" id="hsa:1613"/>
<dbReference type="UCSC" id="uc002lzc.2">
<molecule id="O43293-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="1613"/>
<dbReference type="DisGeNET" id="1613"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000167657.11"/>
<dbReference type="GeneCards" id="DAPK3"/>
<dbReference type="HGNC" id="HGNC:2676">
<property type="gene designation" value="DAPK3"/>
</dbReference>
<dbReference type="HPA" id="HPA028569"/>
<dbReference type="HPA" id="HPA064809"/>
<dbReference type="MIM" id="603289">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O43293"/>
<dbReference type="OpenTargets" id="ENSG00000167657"/>
<dbReference type="PharmGKB" id="PA27144"/>
<dbReference type="eggNOG" id="KOG0032">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XRMJ">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118877"/>
<dbReference type="HOGENOM" id="HOG000233016"/>
<dbReference type="HOVERGEN" id="HBG101549"/>
<dbReference type="InParanoid" id="O43293"/>
<dbReference type="KO" id="K08803"/>
<dbReference type="OMA" id="PWIKVIK"/>
<dbReference type="OrthoDB" id="EOG091G0J2O"/>
<dbReference type="PhylomeDB" id="O43293"/>
<dbReference type="TreeFam" id="TF314166"/>
<dbReference type="Reactome" id="R-HSA-418889">
<property type="pathway name" value="Ligand-independent caspase activation via DCC"/>
</dbReference>
<dbReference type="SABIO-RK" id="O43293"/>
<dbReference type="SignaLink" id="O43293"/>
<dbReference type="SIGNOR" id="O43293"/>
<dbReference type="ChiTaRS" id="DAPK3">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="O43293"/>
<dbReference type="GeneWiki" id="DAPK3"/>
<dbReference type="GenomeRNAi" id="1613"/>
<dbReference type="PRO" id="PR:O43293"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 19"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000167657"/>
<dbReference type="CleanEx" id="HS_DAPK3"/>
<dbReference type="ExpressionAtlas" id="O43293">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O43293">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005884">
<property type="term" value="C:actin filament"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0016605">
<property type="term" value="C:PML body"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008140">
<property type="term" value="F:cAMP response element binding protein binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0043522">
<property type="term" value="F:leucine zipper domain binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008022">
<property type="term" value="F:protein C-terminus binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0017048">
<property type="term" value="F:Rho GTPase binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097190">
<property type="term" value="P:apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071346">
<property type="term" value="P:cellular response to interferon-gamma"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016569">
<property type="term" value="P:covalent chromatin modification"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0035556">
<property type="term" value="P:intracellular signal transduction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0017148">
<property type="term" value="P:negative regulation of translation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030182">
<property type="term" value="P:neuron differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0018105">
<property type="term" value="P:peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0018107">
<property type="term" value="P:peptidyl-threonine phosphorylation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0043065">
<property type="term" value="P:positive regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090263">
<property type="term" value="P:positive regulation of canonical Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030335">
<property type="term" value="P:positive regulation of cell migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2001241">
<property type="term" value="P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000249">
<property type="term" value="P:regulation of actin cytoskeleton reorganization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042981">
<property type="term" value="P:regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010506">
<property type="term" value="P:regulation of autophagy"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000145">
<property type="term" value="P:regulation of cell motility"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008360">
<property type="term" value="P:regulation of cell shape"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051893">
<property type="term" value="P:regulation of focal adhesion assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007346">
<property type="term" value="P:regulation of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007088">
<property type="term" value="P:regulation of mitotic nuclear division"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043519">
<property type="term" value="P:regulation of myosin II filament organization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006940">
<property type="term" value="P:regulation of smooth muscle contraction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006355">
<property type="term" value="P:regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006351">
<property type="term" value="P:transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0156">Chromatin regulator</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0810">Translation regulation</keyword>
<keyword id="KW-0043">Tumor suppressor</keyword>
<feature type="chain" description="Death-associated protein kinase 3" id="PRO_0000085914">
<location>
<begin position="1"/>
<end position="454"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="7">
<location>
<begin position="13"/>
<end position="275"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="7">
<location>
<begin position="19"/>
<end position="27"/>
</location>
</feature>
<feature type="region of interest" description="Activation segment" evidence="6">
<location>
<begin position="161"/>
<end position="204"/>
</location>
</feature>
<feature type="region of interest" description="Leucine-zipper" evidence="34">
<location>
<begin position="427"/>
<end position="441"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="7 8">
<location>
<position position="139"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="35">
<location>
<position position="42"/>
</location>
</feature>
<feature type="binding site" description="Inhibitor" evidence="24">
<location>
<position position="94"/>
</location>
</feature>
<feature type="binding site" description="Inhibitor" evidence="24">
<location>
<position position="96"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="24">
<location>
<position position="50"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="16 20">
<location>
<position position="180"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="16">
<location>
<position position="225"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by autocatalysis and ROCK1" evidence="16 20 24">
<location>
<position position="265"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by autocatalysis, DAPK1 and ROCK1" evidence="15 16 20 26">
<location>
<position position="299"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by autocatalysis" evidence="16">
<location>
<position position="306"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by DAPK1" evidence="15">
<location>
<position position="309"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis and DAPK1" evidence="15 16">
<location>
<position position="311"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by DAPK1" evidence="5 15">
<location>
<position position="312"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by DAPK1" evidence="15">
<location>
<position position="318"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by DAPK1" evidence="15">
<location>
<position position="326"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_042059" evidence="32">
<original>LPPNNSYADF</original>
<variation>ASPIVAPVDA</variation>
<location>
<begin position="313"/>
<end position="322"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_042060" evidence="32">
<location>
<begin position="323"/>
<end position="454"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal adenocarcinoma sample; somatic mutation; greatly reduces kinase activity, increases cell proliferation and cell survival." id="VAR_040438" evidence="21 30">
<original>T</original>
<variation>M</variation>
<location>
<position position="112"/>
</location>
</feature>
<feature type="sequence variant" description="In an ovarian mucinous carcinoma sample; somatic mutation; greatly reduces kinase activity, increases cell proliferation and cell survival." id="VAR_040439" evidence="21 30">
<original>D</original>
<variation>N</variation>
<location>
<position position="161"/>
</location>
</feature>
<feature type="sequence variant" description="In a lung neuroendocrine carcinoma sample; somatic mutation; greatly reduces kinase activity, increases cell proliferation, cell adhesion and cell survival." id="VAR_040440" evidence="21 30">
<original>P</original>
<variation>S</variation>
<location>
<position position="216"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of kinase activity at low concentrations of ATP." evidence="20">
<original>K</original>
<variation>A</variation>
<location>
<position position="42"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of kinase activity." evidence="20">
<original>D</original>
<variation>A</variation>
<location>
<position position="161"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly reduced kinase activity." evidence="30">
<original>T</original>
<variation>A</variation>
<location>
<position position="180"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of kinase activity." evidence="20">
<original>T</original>
<variation>A</variation>
<location>
<position position="225"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation by ROCK1, catalytically inactive." evidence="20">
<original>T</original>
<variation>A</variation>
<location>
<position position="265"/>
</location>
</feature>
<feature type="mutagenesis site" description="Cytoplasmic localization." evidence="26">
<original>RR</original>
<variation>AA</variation>
<location>
<begin position="294"/>
<end position="295"/>
</location>
</feature>
<feature type="mutagenesis site" description="Predominantly nuclear localization." evidence="16">
<original>TT</original>
<variation>AA</variation>
<location>
<begin position="299"/>
<end position="300"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation by ROCK1." evidence="20">
<original>T</original>
<variation>A</variation>
<location>
<position position="299"/>
</location>
</feature>
<feature type="mutagenesis site" description="Predominantly cytoplasmic localization; phosphomimetic." evidence="16">
<original>T</original>
<variation>D</variation>
<location>
<position position="299"/>
</location>
</feature>
<feature type="mutagenesis site" description="Predominantly nuclear localization; when associated with A-434 and A-441." evidence="16">
<original>V</original>
<variation>A</variation>
<location>
<position position="427"/>
</location>
</feature>
<feature type="mutagenesis site" description="Predominantly nuclear localization; when associated with A-427 and A-441." evidence="16">
<original>V</original>
<variation>A</variation>
<location>
<position position="434"/>
</location>
</feature>
<feature type="mutagenesis site" description="Predominantly nuclear localization; when associated with A-427 and A-434." evidence="16">
<original>L</original>
<variation>A</variation>
<location>
<position position="441"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="9"/>
<end position="12"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="13"/>
<end position="21"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="23"/>
<end position="32"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="33"/>
<end position="35"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="38"/>
<end position="46"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="49"/>
<end position="51"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="53"/>
<end position="56"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="58"/>
<end position="70"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="79"/>
<end position="84"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="86"/>
<end position="94"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="101"/>
<end position="108"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="113"/>
<end position="132"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="142"/>
<end position="144"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="145"/>
<end position="148"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="150"/>
<end position="154"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="157"/>
<end position="159"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="171"/>
<end position="175"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="176"/>
<end position="178"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="181"/>
<end position="183"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="186"/>
<end position="189"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="197"/>
<end position="212"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="222"/>
<end position="230"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="238"/>
<end position="241"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="246"/>
<end position="253"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="260"/>
<end position="262"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="266"/>
<end position="271"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="273"/>
<end position="280"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2J90"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3BHY"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5A6N"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5A6O"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O96017"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10356987"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11384979"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11781833"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12917339"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15096528"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15292222"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15367680"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15611134"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15910542"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16219639"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17126281"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17158456"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17953487"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18084323"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18239682"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18995835"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20854903"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21169990"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21408167"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21454679"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21487036"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23454120"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="17126281"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="18239682"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9488481"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000305"/>
<sequence length="454" mass="52536" checksum="56773008A6A61CF0" modified="1998-06-01" version="1">
MSTFRQEDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREE
IEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFL
KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGT
PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY
FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGEDSGRKPERRRLKTT
RLKEYTIKSHSSLPPNNSYADFERFSKVLEEAAAAEEGLRELQRSRRLCHEDVEALAAIY
EEKEAWYREESDSLGQDLRRLRQELLKTEALKRQAQEEAKGALLGTSGLKRRFSRLENRY
EALAKQVASEMRFVQDLVRALEQEKLQGVECGLR
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>